Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
Five LMU researchers have been awarded Consolidator Grants by the European Research Council. Their projects deal with climate change, strokes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback